RBC Capital Markets in a note to investors this week suggested Congress could pass a drug pricing bill in a bid to post a policy “win” ahead of the 2020 elections, according to a CNBC report.
“Dynamics into election look to be [a] perfect storm,” RBC analyst Brian Abrahams said in the note. “While GOP leaders do not see drug pricing reform as a top priority, both [House Speaker Nancy] Pelosi and Trump are very committed to having policy change.”
Health care will be a key issue heading into the 2020 election. Pelosi and President Donald Trump are reportedly working on reform packages, while Sen. Bernie Sanders continues his push for “Medicare for All.”
To read the full report on CNBC, click here.